1. Home
  2. VCEL vs IVT Comparison

VCEL vs IVT Comparison

Compare VCEL & IVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • VCEL
  • IVT
  • Stock Information
  • Founded
  • VCEL 1989
  • IVT 2005
  • Country
  • VCEL United States
  • IVT United States
  • Employees
  • VCEL N/A
  • IVT N/A
  • Industry
  • VCEL Biotechnology: Biological Products (No Diagnostic Substances)
  • IVT Real Estate Investment Trusts
  • Sector
  • VCEL Health Care
  • IVT Real Estate
  • Exchange
  • VCEL Nasdaq
  • IVT Nasdaq
  • Market Cap
  • VCEL 2.1B
  • IVT 2.2B
  • IPO Year
  • VCEL 1997
  • IVT N/A
  • Fundamental
  • Price
  • VCEL $40.12
  • IVT $27.56
  • Analyst Decision
  • VCEL Strong Buy
  • IVT Buy
  • Analyst Count
  • VCEL 8
  • IVT 5
  • Target Price
  • VCEL $62.00
  • IVT $31.75
  • AVG Volume (30 Days)
  • VCEL 558.9K
  • IVT 413.3K
  • Earning Date
  • VCEL 07-31-2025
  • IVT 07-29-2025
  • Dividend Yield
  • VCEL N/A
  • IVT 3.46%
  • EPS Growth
  • VCEL 521.85
  • IVT 140.80
  • EPS
  • VCEL 0.05
  • IVT 0.24
  • Revenue
  • VCEL $238,541,000.00
  • IVT $280,947,000.00
  • Revenue This Year
  • VCEL $23.03
  • IVT $10.52
  • Revenue Next Year
  • VCEL $24.52
  • IVT $7.55
  • P/E Ratio
  • VCEL $772.69
  • IVT $114.06
  • Revenue Growth
  • VCEL 14.80
  • IVT 7.90
  • 52 Week Low
  • VCEL $34.87
  • IVT $25.21
  • 52 Week High
  • VCEL $63.00
  • IVT $31.65
  • Technical
  • Relative Strength Index (RSI)
  • VCEL 51.37
  • IVT 53.06
  • Support Level
  • VCEL $34.87
  • IVT $27.28
  • Resistance Level
  • VCEL $41.00
  • IVT $27.74
  • Average True Range (ATR)
  • VCEL 1.77
  • IVT 0.47
  • MACD
  • VCEL 0.21
  • IVT 0.09
  • Stochastic Oscillator
  • VCEL 67.83
  • IVT 85.25

About VCEL Vericel Corporation

Vericel Corp is a fully integrated, commercial-stage biopharmaceutical company and a provider of therapies for the sports medicine and severe burn care markets. It markets cell therapy products in the United States, MACI (autologous cultured chondrocytes on porcine collagen membrane); Epicel (cultured epidermal autografts); and NexoBrid. The Company operates its business in the U.S. in one reportable segment; the research, product development, manufacture, and distribution of cellular therapies and specialty biologics for use in the treatment of specific conditions.

About IVT InvenTrust Properties Corp.

InvenTrust Properties Corp is the United States of America based company qualified as a REIT (Real Estate Investment Trust). It is focused on owning, leasing, redeveloping, acquiring and managing a multi-tenant retail platform. The company's wholly-owned and managed retail properties include grocery-anchored community and neighborhood centers and power centers, including those classified as necessity-based. InvenTrust operates through a single segment i.e. multi-tenant retail.

Share on Social Networks: